Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
Not yet recruiting · NCT07166549 · Registry updated 2025-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Inflammation, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 | 2025-12-24 | NCT07166549 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Basel, Switzerland | 243 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Basel, Division of Hematology or Medical Oncology | Basel | Switzerland | 1 |